本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Abeona Therapeutics Inc

5.42
-0.0650-1.19%
盤後5.470.0530+0.98%19:30 EDT
成交量:159.80萬
成交額:871.65萬
市值:3.09億
市盈率:-4.83
高:5.66
開:5.55
低:5.40
收:5.48
52周最高:7.65
52周最低:4.00
股本:5,704.90萬
流通股本:3,691.95萬
量比:1.20
換手率:4.33%
股息:- -
股息率:- -
每股收益(TTM):-1.1200
每股收益(LYR):1.01
淨資產收益率:-43.13%
總資產收益率:-24.55%
市淨率:2.41
市盈率(LYR):5.36

資料載入中...

2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/06

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/03/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/20

重要事件披露

Form 8-K - Current report
2026/03/17

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/17

重要事件披露

Form 8-K - Current report
2026/03/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities